Literature DB >> 27115208

Laboratory Investigations for Diagnosis of Autoimmune and Inflammatory Periocular Disease: Part II.

Archana Srinivasan1, Teri T Kleinberg, Ann P Murchison, Jurij R Bilyk.   

Abstract

PURPOSE: To review the important laboratory serological investigations routinely performed for the diagnosis of autoimmune and inflammatory diseases of the orbit and ocular adnexa.
METHODS: Review of the literature as well as personal clinical experience of the authors. Due to the extensive nature of the topic, the review has been split into 2 parts. Part I covers thyroid eye disease, IgG4-related disease, and myasthenia gravis. In part II of the review, sarcoidosis, vasculitis, Sjögren syndrome, and giant cell arteritis will be discussed.
RESULTS: Several relatively specific serologic tests are available for the diagnosis of a variety of inflammatory and serologic diseases of the orbit.
CONCLUSION: In cases of limited orbital or sino-orbital disease, serologic testing may be negative in a significant number of patients. Specifically, the clinician should be wary of ruling out limited orbital sarcoid or sinoorbital granulomatosis with polyangiitis based on serologic testing alone. Part I of this review has covered serologic testing for thyroid eye disease, IgG4-related disease, and myasthenia gravis. In part II, the authors discuss serologic testing for sarcoidosis, vasculitis, Sjögren syndrome (SS), and giant cell arteritis (GCA).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27115208     DOI: 10.1097/IOP.0000000000000701

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  2 in total

1.  Autoimmune markers in screening for orbital inflammatory disease.

Authors:  Terence Ang; Valerie Juniat; Dinesh Selva
Journal:  Eye (Lond)       Date:  2022-04-19       Impact factor: 3.775

Review 2.  CT and MR imaging of orbital inflammation.

Authors:  Teresa A Ferreira; P Saraiva; S W Genders; M V Buchem; G P M Luyten; J-W Beenakker
Journal:  Neuroradiology       Date:  2018-10-11       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.